Dean Petkanas, CEO, Kannalife, Inc.

CEO at Kannalife
On the record
Represented by:
Recent Quotes
Sign up to view all
  • Dr. Honoré’s successes are attributed to his ability to translate science to product opportunities and his understanding of the need to integrate research, clinic, market and financial stakeholders. We are pleased and excited to have him on board. His clinical drug development experience and knowledge in the CNS and PNS space is invaluable and timely to our current efforts to head towards the clinic with KLS-13019.

    30 September 2020